Diagnosis and Emergent Management of Anaphylaxis in Children
Advances in Pediatrics, ISSN: 0065-3101, Vol: 52, Page: 195-206
2005
- 6Citations
- 15Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations6
- Citation Indexes6
- CrossRef4
- Captures15
- Readers15
- 15
Article Description
Anaphylactic and anaphylactoid reactions are serious, potentially life-threatening reactions with well-described clinical manifestations. Although the pathophysiology of these reactions varies with the offending agent and route of exposure, the treatment remains the same. Attention to airway, breathing, and circulation and the prompt administration of epinephrine remain the mainstays of therapy. Once an at-risk individual is identified, the proper instruction on the avoidance of the offending agent, the use of the EpiPen, and referral to a specialist in the treatment of allergic reactions may be instrumental in the future health and safety of that patient. Copyright 2005, Mosby, Inc. All rights reserved.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0065310105000058; http://dx.doi.org/10.1016/j.yapd.2005.03.004; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=24644482427&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/16124341; https://linkinghub.elsevier.com/retrieve/pii/S0065310105000058; https://dx.doi.org/10.1016/j.yapd.2005.03.004
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know